David G Armstrong
Overview
Explore the profile of David G Armstrong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
479
Citations
11686
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Klonoff D, Levy B, Jaasma M, Bharara M, Edgar D, Nasr C, et al.
J Pain Res
. 2024 Sep;
17:3063-3074.
PMID: 39308991
Purpose: The recent SENZA-PDN study showed that high-frequency (10kHz) spinal cord stimulation (SCS) provided significant, durable pain relief for individuals with painful diabetic neuropathy (PDN), along with secondary benefits, including...
12.
Armstrong D, Orgill D, Galiano R, Glat P, Carter M, Hanft J, et al.
Int Wound J
. 2024 Sep;
21(9):e70029.
PMID: 39245798
Diabetic foot complications that lead to lower extremity amputations pose a significant challenge to the entire global health system. In this multicentre clinical trial, 26 patients with chronic Wagner one...
13.
Accelerating diabetic wound healing with Ramulus Mori (Sangzhi) alkaloids via NRF2/HO-1/eNOS pathway
Xiao F, Rui S, Zhang X, Ma Y, Wu X, Hao W, et al.
Phytomedicine
. 2024 Sep;
134:155990.
PMID: 39243750
Diabetic foot ulcers (DFUs) represent a severe complication of diabetes mellitus. Ramulus Mori (Sangzhi) alkaloids (SZ-A), an approved oral medication for type 2 diabetes, have not been explored for their...
14.
Staniszewska A, Game F, Nixon J, Russell D, Armstrong D, Ashmore C, et al.
Diabetes Care
. 2024 Sep;
47(11):1958-1968.
PMID: 39240785
Objective: Diabetes affects 537 million people globally, with 34% expected to develop foot ulceration in their lifetime. Diabetes-related foot ulceration causes strain on health care systems worldwide, necessitating provision of...
15.
Basu P, Banerjee A, Okoro P, Masoumi A, Kanjilal B, Akbari M, et al.
Adv Healthc Mater
. 2024 Sep;
13(29):e2401461.
PMID: 39235365
Biosensors have led to breakthroughs in the treatment of chronic wounds. Since the discovery of the oxygen electrode by Clarke, biosensors have evolved into the design of smart bandages that...
16.
Hawkins B, Li J, Wilkins L, Carman T, Reed A, Armstrong D, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(3):100015.
PMID: 39131959
No abstract available.
17.
Jones P, Armstrong D, Frykberg R, Davies M, Rowlands A
Diabet Med
. 2024 Jul;
41(10):e15407.
PMID: 39012919
Aims: Incorrectly fitting footwear (IFF) poses a risk of trauma to at-risk feet with diabetes. The aim of this systematic review was to summarise and assess the evidence that IFF...
18.
Tettelbach W, Kelso M, Armstrong D
J Wound Care
. 2024 Jul;
33(Sup7):S16-S23.
PMID: 38973641
No abstract available.
19.
Orkin R, Sharma A, John J, Armstrong D
Adv Wound Care (New Rochelle)
. 2024 Jul;
PMID: 38970426
Sterility and reduction of the bioburden are crucial for healing in chronic wounds such as diabetic foot ulcers. Although there are methods for measuring bioburdens, such as semiquantitative analysis of...
20.
Rui S, Dai L, Zhang X, He M, Xu F, Wu W, et al.
J Control Release
. 2024 Jun;
372:221-233.
PMID: 38909697
The utilization of platelet-rich plasma (PRP) has exhibited potential as a therapeutic approach for the management of diabetic foot ulcers (DFUs). However, it is currently not well understood how the...